Podcasts and Videos - BioPharm International

Podcasts and Videos

Click an icon above to automatically deliver all podcasts to your iTunes or rich media player

Videos:

Alnylam Discusses RNAi Delivery
Alnylam Pharmcaeuticals, a company specializing in RNA-interference therapeutics, talks to BioPharm International's Amy Ritter about its RNAi delivery system and its early-stage clinical pipeline. Listen now.

USP 2011 Symposium Preview
A series of videos from the US Pharmacopeia (USP) provides highlights of the 2011 USP Science & Standards Symposium on Biologics & Biotechnology, taking place Oct. 3-6, 2011, in Seattle. Get more information on the symposium (Posted September 2011). Watch Now>>>

Pharma Faceoff: Should Pharma Invest in R&D or Search for External Drug Candidates?
Join Shire's Renee Cohen, Sanofi's Ray Jupp, Deutsche Bank's Barbara Ryan, Ken Kaitin of Tufts University, and Charlotte Sibley as they debate how pharma can find new drug candidates and refill the pipeline. Audio and Video (Posted Summer 2011). Watch Now>>>

Pharma Faceoff: Vermont's Data Mining Law
Physician privacy vs. Rep Free Speech: Before the Supreme Court decides Sorrell v. IMS Health, find out what's at stake. Jody Fisher, vice-president of marketing for SDI and Frank Pasquale, the Schering-Plough Professor in Health Care Regulation and Enforcement at Seton Hall Law School, face off in this episode of Pharma Faceoff. Audio adn Video (Posted Summer 2011). Watch Now>>>

EDITORIAL PODCAST SERIES:

Finox Biotech's Anjan Selz on Meeting Regulatory Expectations
In this second of three podcasts, Anjan Selz, cofounder and CEO of Finox Biotech, discusses his company's interactions with EMA and FDA. Posted Jan. 2012 as part of BioPharm International's Basic Training Drug Development series.

Finox Biotech's Anjan Selz on Biosimilar Development
In this first of three podcasts, Anjan Selz, cofounder and CEO of Finox Biotech, describes how he decided to move away from the “me too” approach to biosimilars and focus on product differentiation. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Deelopment series.

The Future of Drug Design
In this final podcast of three, BioPharm International interviews Dr. Trevor Hallam, chief scientific officer at Sutro Biopharma, a company that has developed a cell-free system for protein expression. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Deelopment series.

Future GMP Manufacturing Facility
In this second of three podcast interviews, Dr. Hallam, chief scientific officer at Sutro Biopharma, describes a future GMP facility for the production therapeutic proteins and peptides. Posted Dec. 201 1as part of BioPharm International's Basic Training Drug Deelopment series.

MicroRNA Drug Delivery
Balkrishnen Bhat, senior director and head of chemistry at Regulus, discusses core technology in microRNA drug delivery (Posted November 2011 as part of BioPharm International's Basic Training Drug Deelopment series). Listen>>>

Biotech Outsourcing Strategies
Balkrishnen Bhat, senior director and head of c hemistry at Regulus, discusses the company's outsourcing strategies. (Posted November 2011as part of BioPharm International's Basic Training Drug Deelopment series). Listen>>>

Cell-free Protein Expression
Dr. Trevor Hallam, chief scientific officer at Sutro Biopharma, discusses a nontraditional approach for expressing therapeutic proteins and peptides. (Posted November 2011 as part of BioPharm International's Basic Training Drug Deelopment series). Listen>>>

US Pharmacopeia Leaders Discuss the Future of Biologics and Biosimilars
Senior Managing Editor Angie Drakulich interviews leaders and speakers from the US Pharmacopeia 2011 Science and Standards Symposium on emerging topics in biologics, including biosimilars, new USP monoclonal antibody chapters, FDA approvals, and more (Posted October 2011). Featuring USP's Tina Morris and Matthew van Hook, and Engel & Novitt's Gillian Woollett.

A Conversation with NIH Director Francis S. Collins
Director of the National Institutes of Health (NIH), Dr. Francis Collins, discusses NIH's efforts to improve global healthcare, including an update on the human genome project, a focus on infectious and rare diseases in the developing world, and R&D grants for small businesses. Podcast interview by Sr. Managing Editor Angie Drakulich, as part of the 2011 BIO Convention and BioVentures for Global Health Partnering for Global Health Forum (Posted June 2011). Listen>>>

WATERS PODCAST SERIES:

UPLC, QTof, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science

Episode Number 6:Unraveling the Analytical Complexity of Subunit Vaccines
Join St John Skilton as he discusses modern trends towards Protein Subunit Vaccines and the advantages for manufacturing flexibility and better reponse times for pandemics. Listen>>>

Episode Number 5: Advancing Peptide Mapping with Informatics Support for Multiplexed Peptide Fragmentation Data
Selecting an efficient peptide mapping LC/MS methodology and proper informatics tools are critical for obtaining quick and complete information about a biotherapeutic protein. Listen>>>

Episode Number 4: Why Ion Mobility is Shaping the Future
This podcast will show how IMS has enabled studies of protein conformation, pegylated proteins, top-down sequencing and characterization of protein glycosylation. Listen>>>

Episode Number 3: Advances in glycan analysis
In this podcast series, we?ll provide you with a firm knowledge of the latest technological innovations in LC and LC/MS that have been designed to address and advance the very specific needs of the many applications areas in the biopharmaceutical laboratory. Listen>>>

Episode Number 2: Getting more specificity in host cell protein analysis using proteomics approaches
In this podcast, we will introduce the capabilities added by the analysis of residual Host Cell Proteins by novel LC/MS techniques, providing more information on which an organization can act in this challenging application area. Listen>>>

Episode Number 1: Current challenges in oligonucleotide analysis.
Today we'll be discussing some of the primary analytical challenges faced by oligotherapeutic and oligodiagnostic manufacturers for characterizing and quantitating oligonucleotides. Listen>>>

PREVIOUS PODCASTS:

Using Stability Models to Predict Drug Characteristics at the End of Shelf Life
Listen to this interview with Peter Sprinz, PhD, a senior research scientist at Eli Lilly, to learn about using stability models to predict drug characteristics at the end of shelf life. Listen>>>

Opportunities in Biosimilars
Michael Kamarck, president of Merck BioVentures, talks about the opportunities and challenges in biosimilars Listen>>>

Microbial Fermenter Equipment Calibration
Kirsten Hayda, process development engineer at Amgen, discusses the benefits of testing fermentation equipment Listen>>>

Biopharmaceutical Manufacturing in India: The Challenges
In this interview, Ajit Mahadevan, Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young, discusses current trends and challenges of outsourcing biomanufacturing-related activities to India. Listen>>>

Solving Tomorrow´s Downstream Processing Challenges
Listen in and hear tips for using improved processing technologies, better analytics, and advanced process development tools. acquisition? Listen>>>

Pfizer´s Maddaluna on Integrating Wyeth´s Manufacturing Organization
What is the future of Pfizer´s global manufacturing network following the Wyeth acquisition? Listen>>>

Quality by Design: Where We Stand Now
On what aspects of Quality by Design is there now consensus within the industry and regulatory bodies, and what remains to be sorted out? Listen>>>

Biopharmaceutical Job Market: 2010 & Beyond
Current and future employment trends for the biopharmaceutical industry. Listen>>>
FDA´s Keith Webber on Setting Specifications.
He talks about how product specifications for biological products apply to individual samples or averages; the use of specifications vs. control limits; stability results, and more. Listen>>>

The Future of Biopharmaceutical Innovation
BIO’s CEO Jim Greenwood talks about follow-on biologics and the effect of the economy on small biotechs and future biopharmaceutical innovation. Listen>>>

The Environmental Impact of Disposables
Are single-use technologies bad for the environment? Listen>>>

Cell Culture Manufacturing Capacity: Outlook to 2013 (8:09)
Interview with Jim Miller, president, PharmSource Information Services, and Tom Ransohoff, Senior Consultant, BioProcess Technology Consultants. Will your CMO have the capacity you need in five years? Hear the latest outlook, and learn what factors will influence that answer.

Download Adobe Flash Player

For webcasts, click here

BioPharm podcasts are developed and produced by BioPharm International, a division of Advanstar Communications, Inc., which is solely responsible for podcast content.